Healio

FDA to review new drug application for Spiriva Respimat for asthma

Please provide your email address to receive an email when new articles are posted on . We were unable to process your request. Please try again later. If you continue to have this issue please ...
Medscape

Tiotropium Respimat as Safe as HandiHaler

BARCELONA, Spain — The risk for mortality in chronic obstructive pulmonary disease (COPD) patients being treated with tiotropium is the same whether the drug is delivered by the Respimat Soft Mist ...
The New England Journal of Medicine

Tiotropium Respimat Inhaler and the Risk of Death in COPD

Tiotropium delivered at a dose of 5 μg with the Respimat inhaler showed efficacy similar to that of 18 μg of tiotropium delivered with the HandiHaler inhalation device in placebo-controlled trials ...
Monthly Prescribing Reference

Spiriva Respimat Approved for COPD Maintenance

Tiotropium as Asthma Add-On Treatment Shows Promise Boehringer Ingelheim announced that the Food and Drug Administration (FDA) has approved Spiriva Respimat (tiotropium bromide) inhalation spray for ...
Medscape

FDA OKs Mist Spray Form of Tiotropium (Spiriva Respimat)

The US Food and Drug Administration (FDA) yesterday approved an inhalation spray version of tiotropium bromide (Spiriva Respimat, Boehringer Ingelheim) for maintenance treatment of chronic obstructive ...
Monthly Prescribing Reference

Spiriva Respimat Gains Indication and New Dosage Strength

Boehringer Ingelheim announced that Spiriva Respimat (tiotropium bromide) is now available for the long-term maintenance treatment of asthma in patients ages ≥12 years. Boehringer Ingelheim announced ...
Healio

Spiriva Respimat safe, tolerable as add-on therapy in adolescents with asthma

Please provide your email address to receive an email when new articles are posted on . SAN ANTONIO — Once-daily tiotropium bromide as an add-on to inhaled corticosteroid therapy demonstrated ...
FiercePharma

Phase III results: tiotropium* Respimat® is effective in symptomatic asthma patients irrespective of their allergic status

SAN ANTONIO, Texas--(BUSINESS WIRE)--Tiotropium delivered once daily via Respimat™ significantly improved lung function and reduced asthma exacerbations in patients who remain symptomatic despite ...
PharmaTimes

BI’s Spiriva Respimat moves closer to US approval

Boehringer Ingelheim has been boosted by advisors to the US Food and Drug Administration who have backed the mist version of the company’s chronic obstructive pulmonary disease Spiriva. Boehringer ...
Business Wire

FDA approves Boehringer Ingelheim’s Stiolto™ * Respimat ® as once-daily maintenance treatment for COPD

INGELHEIM, Germany--(BUSINESS WIRE)--Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) approved once-daily Stiolto™ Respimat ® (tiotropium bromide and olodaterol) ...
elEconomista

Tiotropium Respimat® improved lung functionin children with asthma aged 6-17 and is well-tolerated compared toplacebo in children aged 1-171-5

Boehringer Ingelheim announced today new study results from the Phase III CanoTinA-asthma ® trial that showed adding tiotropium Respimat ® to maintenance asthma therapy significantly improved lung ...
Europa Press

New SPIRIVA(R) Respimat(R) Inhaler Completes European Approval Process for COPD (1)

-- Patients to Benefit From Easy-to-Use Inhaler With Enhanced Drug Delivery Boehringer Ingelheim and Pfizer today announced successful completion of the approval process for authorisation to market ...